Cargando…

Red blood cell alloantibodies in paediatric transfusion in sub‐Saharan Africa: A new cohort and literature review

Blood transfusion support predisposes transfused children to the risk of erythrocyte alloimmunization in Sub‐Saharan Africa. A cohort of 100 children receiving one to five blood transfusions were recruited for screening and identification of irregular antibodies using gel filtration technique. The m...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gadji, Macoura, Cobar, Guéda, Thiongane, Alioune, Senghor, Alioune Badara, Seck, Rose, Faye, Blaise Félix, Seck, Moussa, Guéye, Youssou Bamar, Sy, Diariétou, Sall, Abibatou, Toure, Awa Oumar, Diéye, Tandakha Ndiaye, Diop, Saliou
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2023
Materias:	Sickle Cell, Thrombosis, and Classical Haematology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10188460/ https://www.ncbi.nlm.nih.gov/pubmed/37206261 http://dx.doi.org/10.1002/jha2.645

Ejemplares similares

Homozygous sickle cell disease related mortality in Senegal (2011–2020)
por: Seck, Moussa, et al.
Publicado: (2021)

Transfusion Practice, Post-Transfusion Complications and Risk Factors in Sickle Cell Disease in Senegal, West Africa
por: Seck, Moussa, et al.
Publicado: (2022)

Antiphospholipid Antibodies and Systemic Scleroderma
por: Touré, Awa Oumar, et al.
Publicado: (2013)

Flower-Like Plasma Cell Nuclei in Multiple Myeloma
por: Sall, Abibatou, et al.
Publicado: (2021)

Characteristics of chronic lymphocytic leukemia in Senegal
por: Sall, Abibatou, et al.
Publicado: (2016)

Smudge cells percentage on blood smear is a reliable prognostic marker in chronic lymphocytic leukemia
por: Sall, Abibatou, et al.
Publicado: (2022)

Circumcision in hemophilia using low quantity of factor concentrates: experience from Dakar, Senegal
por: Seck, Moussa, et al.
Publicado: (2017)

Risk Factors for Thrombosis in an African Population
por: Fall, Awa OT, et al.
Publicado: (2014)

Clinical outcome and incidence of inhibitor development in severe hemophilia patients receiving low-dose prophylaxis: a 3-year follow-up study in Senegal, West Africa
por: Touré, Sokhna Aïssatou, et al.
Publicado: (2023)

Acute kidney injury in Jamaicans with sickle cell disease hospitalized with COVID‐19 infection
por: Fisher, Lori‐Ann, et al.
Publicado: (2023)

A phase III, randomised, double‐blind, multi‐national clinical trial comparing SB12 (proposed eculizumab biosimilar) and reference eculizumab in patients with paroxysmal nocturnal haemoglobinuria
por: Jang, Jun Ho, et al.
Publicado: (2022)

Impact of age‐dependent red blood cell parameters on α‐globin gene genotyping in children
por: Nissen, Peter H., et al.
Publicado: (2022)

Procoagulant factors and future risk of arterial cardiovascular disease in patients with prior venous thrombosis: A cohort study
por: Yap, Eng Soo, et al.
Publicado: (2023)

UK media reporting of NICE recommendation of crizanlizumab for patients with sickle cell disease
por: Buka, Richard J, et al.
Publicado: (2022)

SARS‐CoV‐2 infection results in upregulation of Plasminogen Activator Inhibitor‐1 and Neuroserpin in the lungs, and an increase in fibrinolysis inhibitors associated with disease severity
por: Toomer, Kevin H., et al.
Publicado: (2023)

Clinical and laboratory characteristics of patients with symptomatic secondary immunodeficiency following the treatment of haematological malignancies
por: Shields, Adrian M., et al.
Publicado: (2023)

Overuse of corticosteroids in patients with immune thrombocytopenia (ITP) between 2011 and 2017 in the United States
por: Cuker, Adam, et al.
Publicado: (2023)

Family planning needs of young adults with sickle cell disease
por: Linton, Elizabeth A., et al.
Publicado: (2023)

Real‐world complication burden and disease management paradigms in transfusion‐related β‐thalassaemia in Greece: Results from ULYSSES, an epidemiological, multicentre, retrospective cross‐sectional study
por: Kattamis, Antonis, et al.
Publicado: (2023)

Unsupervised machine learning algorithms identify expected haemorrhage relationships but define unexplained coagulation profiles mapping to thrombotic phenotypes in hereditary haemorrhagic telangiectasia
por: Mukhtar, Ghazel, et al.
Publicado: (2023)

Hydroxyurea treatment for adult sickle cell anemia patients in Kinshasa
por: Kabuyi, Paul Lumbala, et al.
Publicado: (2023)

Comparative analysis of opioid use in sickle cell crisis in an urban facility in Ghana
por: Opoku‐Agyakwa, Marian, et al.
Publicado: (2023)

Results of a phase 1/2 study of cemdisiran in healthy subjects and patients with paroxysmal nocturnal hemoglobinuria
por: Gaya, Anna, et al.
Publicado: (2023)

Clinical and haematological characteristics of 38 individuals with Hb G‐Makassar in Malaysia
por: Esa, Ezalia, et al.
Publicado: (2023)

Impact of COVID‐19 on incidence, clinical presentation, and prognosis of acute chest syndrome in patients with sickle cell disease
por: Dubois, Gabin, et al.
Publicado: (2023)

Sickle cell anemia and pregnancy: Profile of hemodynamic changes in sickle cell pregnant women in Kinshasa
por: Mikobi, Tite Minga, et al.
Publicado: (2023)

HLA haplotype frequencies and diversity in patients with hemoglobinopathies
por: Scigliuolo, Graziana M., et al.
Publicado: (2023)

Empowering patients with sickle cell anemia and their families through innovative educational methods
por: Plett, Riley, et al.
Publicado: (2023)

Disease knowledge and health literacy in parents of children with sickle cell disease
por: Ikediashi, Bonaventure G., et al.
Publicado: (2023)

Rosai Dorfman disease diagnosed by fine-needle aspiration cytology in a young man with HIV infection
por: Sall, Abibatou, et al.
Publicado: (2015)

Les maladies chroniques non transmissibles chez les militaires sénégalais: étude transversale en 2013
por: Aziz, Ndiaye Abdoul, et al.
Publicado: (2015)

Assessment of potentially preventable hospitalizations in the regional hospital of Saint-Louis, Senegal
por: Ndiaye, Abdoul Aziz, et al.
Publicado: (2017)

Efficacy and Safety of Manual Partial Red Cell Exchange in the Management of Severe Complications of Sickle Cell Disease in a Developing Country
por: Faye, B. F., et al.
Publicado: (2017)

Plasma exchange for COVID‐19 thrombo‐inflammatory disease
por: Arulkumaran, Nishkantha, et al.
Publicado: (2020)

Is sickle cell disease a risk factor for severe COVID‐19 outcomes in hospitalized patients? A multicenter national retrospective cohort study
por: Abdulrahman, Abdulkarim, et al.
Publicado: (2021)

Clusters of pain trajectories among patients with sickle cell disease hospitalized for vaso‐occlusive crisis: A data‐driven approach
por: Rodday, Angie Mae, et al.
Publicado: (2020)

Patterns of healthcare utilization among patients with sickle cell disease hospitalized with pain crises
por: Rodday, Angie Mae, et al.
Publicado: (2020)

Mild anemia as a single independent predictor of mortality in patients with COVID‐19
por: Tremblay, Douglas, et al.
Publicado: (2021)

In‐hospital mortality in SARS‐CoV‐2 stratified by hemoglobin levels: A retrospective study
por: Al‐Jarallah, Mohammed, et al.
Publicado: (2021)

Blood group type A secretors are associated with a higher risk of COVID‐19 cardiovascular disease complications
por: Mankelow, Tosti J., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_ero4chk16pbkiuqv3gjsp2d8h0